Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease. [PDF]
Puig L +14 more
europepmc +1 more source
Early Mycobacterial Antigens in the Immunodiagnosis of Latent Tuberculosis Infection. [PDF]
Utegenova A +6 more
europepmc +1 more source
Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV. [PDF]
Dyer E +4 more
europepmc +1 more source
Age-stratified prevalence of latent tuberculosis infection in Ulaanbaatar, Mongolia: a facility-based cross-sectional study. [PDF]
Narmandakh E +15 more
europepmc +1 more source
Prevalence of latent tuberculosis infection in Malaysia: the first systematic review and meta-analysis. [PDF]
Wada Y +5 more
europepmc +1 more source
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
D. Zenner +5 more
semanticscholar +1 more source
Twelve-dose regimen for latent TB infection
You have been diagnosed with latent TB infection -- What is latent TB infection? -- Why take treatment for latent TB infection? -- What is the 12-dose regimen? -- What is your treatment schedule?
core
The cascade of care for latent tuberculosis infection in Malaysia: a cohort analysis. [PDF]
Yeoh AST +9 more
europepmc +1 more source
Prevalence of Latent Tuberculosis Infection in Vulnerable Groups in the State of Santa Catarina, Brazil. [PDF]
Carvalho EDR, Kupek E.
europepmc +1 more source
Immunological Evidence of Latent Tuberculosis Infection among Noncontacts and Contacts with Index Tuberculosis Patients. [PDF]
Verma AK +8 more
europepmc +1 more source

